Figainin 1 

General Information


DRACP ID  DRACP01020

Peptide Name   Figainin 1 

Sequence  FIGTLIPLALGALTKLFK

Sequence Length  18

UniProt ID  A0A2L2DDE6  

PubChem CID  Not available

Origin  B. raniceps skin secretion

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10 Mouse melanoma Carcinoma IC50=10.5 µM (0.020 g/L) MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=13.7 µM (0.026 g/L) MTT assay 24h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=11.1 µM (0.021 g/L) MTT assay 24h 1

Hemolytic Activity  Human red blood cells: HC50 =10 µM (0.019 g/L) (testing time is 24 h)

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50=13 µM (0.025 g/L) (testing time is 24 h)

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01020

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H158N20O21

Absent amino acids  CDEHMNQRSVWY

Common amino acids  L

Mass  221985

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  11

Net charge  2

Boman Index  2966

Hydrophobicity  142.22

Aliphatic Index  162.78

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32967114

Title  Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties

Doi 10.3390/antibiotics9090625

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.